PTC Therapeutics: Q4 Earnings Snapshot

SOUTH PLAINFIELD, N.J. (AP) — SOUTH PLAINFIELD, N.J. (AP) — PTC Therapeutics Inc. (PTCT) on Tuesday reported a loss of $170.9 million in its fourth quarter.

The South Plainfield, New Jersey-based company said it had a loss of $2.35 per share.

The results missed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $1.96 per share.

The biopharmaceutical company posted revenue of $167.4 million in the period, which also missed Street forecasts. Three analysts surveyed by Zacks expected $179.2 million.

For the year, the company reported a loss of $559 million, or $7.79 per share. Revenue was reported as $698.8 million.

PTC Therapeutics expects full-year revenue in the range of $940 million to $1 billion.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on PTCT at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up